Handbook_Volume III

65 1. Aspetti Generali [25]. Halter J, Kodera Y, Ispizua AU, et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94(1):94–101. [26]. Hequet OJ. Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility. J Blood Med. 2015;6:55–67. [27]. Hoffman R, et al. Hematology, Basic principles and practice. In: Practical aspects of stem cell collection, vol. 2: Churchill Livingstone-Elsevier; 2008. p. 1695–7. ISBN: 978-0-443-06715-0. [28]. Iacobone E, Brescia F, Capozzoli G, Elisei D, Giustivi D, La Greca A et al. Terminology for vascular access devices. Journal Vascular Surgery. 2021 Jul 74(1):344-345 [29]. IBMDR. Italian Bone Marrow Donor Registry. Standard di funzionamento. Revisione 2021 e successive revisioni [30]. Ipe TS, Marques MB. Vascular access for therapeutic plasma exchange. Transfusion 2018 Feb;58 Suppl 1. 580-589 [31]. ITCBN – Linee Guida per la raccolta e la conservazione del sangue cordonale ad uso autologo-dedicato. Rev. 0 del 18 novembre 2016 [32]. ITCBN – Requisiti organizzativi, strutturali e tecnologici minimi per l’esercizio delle attività sanitarie delle banche di sangue da cordone ombelicale. GU 288 dell’11-12-2009 [33]. JACIE - Joint Accreditation Committee-ISCT and EBMT. FACT-JACIE. International standard. Standard for Haemopoietic Progenitor Cell Collection, Processing and Transplantation. 8.1th Edition 14 December 2021 [34]. Jöris M, Pustjens E , Mengling T, Fechter M, Wiersum-Osselton J, Bokhorst A et al. New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation. Cell Tissue Bank. 2021 Jun;22(2):191-197. [35]. Kenyon M, Babic A. Haematopoietic stem cell mobilization and apheresis: a practical guide for nurses and other allied health care professionals. The European Blood and Marrow Transplantation Textbook for Nurses, 2009. [36]. Klaus J. Effect of CD34. cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Eur J Haematol. 2007;78(1):21–8. [37]. Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Böhler J. Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation Nephrol Dial Transplan 2009 Jul;24(7):2244-5 [38]. Mathe G. Treatment of leukemia with allogeneic bone marrow transplantation. Brux Med. 1964 May 17;44:559-62. [39]. Nuss S, Barnes Y, Fisher V, Olson E, Skeens M. In: Hematopoietic cell transplantation. In: Baggott C, Fochtman D, Foley GV, Kelly KP, editors. Nursing care of children and adolescent with cancer and blood disorders. 4th ed: APHON Association of Pediatric Hematology/Oncology Nurses; 4th edition 2011. p. 405–66. [40]. O’Leary MF, Dunbar NM, Kim HC, Draper NL, Linenberger M, Schwartz J et al. Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC don subcommittee. Journal of Clinical Apheresis 2016 Dic 31(6):529534 [41]. Parmar G, Wu John WY and Chan KW. Bone marrow donation in childhood: one donor’s perspective. Psycho-Oncology 2003;12: 91–94 [42]. Passweg JR , Baldomero E, Chabannon C, Basak GW, de la Cámara R, Corbacioglu S et al. European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021 Jul;56(7):1651-1664. [43]. Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA. Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. Biol Blood Marrow Transplant. 2016;22(1):96–103. [44]. Pierelli L, Perseghin P, Marchetti M, et al. Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Societa Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process. Transfusion. 2012;52(4):893–905. [45]. Pulsipher MA, Levine JE, Hayashi RJ, Chan KW, Anderson P, Duerst R et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996–2003. Bone Marrow Transplant. 2005;35(4):361–7. [46]. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009 Apr 9;113(15):3604-11. [47]. Salazar-Riojas R, Garcia-Lozano JA, Valdes-Galvan M, Martinez-Gonzalez O, Cantu-Rodriguez OG, Gonzalez-Llano O et al. Effective Collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large-volume apheresis procedure. Journal of Clinical Apheresis 2015 Oct;30(5):281-287 [48]. Santos GW. Bone marrow transplantation in hematologic malignancies. Current status. Cancer. 1990 Feb 1;65(3 Suppl):786-91. [49]. Schoemans H, Theunissen K, Maertens J, et al. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant. 2006;38:83–93. [50]. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991 Jan 15;77(2):400-9. [51]. Sierra J, Radich J, Hansen JA, Martin PJ, Petersdorf EW, Bjerke J et al. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1997 Aug 15;90(4):1410-4. [52]. Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji R, Marktel S et al. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study. Blood. 2012;119(12):2935–42. [53]. Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart SJ, Civin CI. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol. 1986 Oct;14(9):878-86. [54]. Thomas ED. Intravenous Infusion of Bone Marrow in Patients Receiving Radiation and Chemotherapy. New Eng Journal of medicine, 12-09-1957 [55]. Thomas ED. Stem cell transplantation: past, present and future. Arch Immunol Ther Exp (Warsz). 1997;45(1):1-5. [56]. Toro JJ, Morales M, Loberiza F, Ochoa-Bayona JL, Freytes CO. Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell trans- plantation: results of an international survey. Support Care Cancer. 2007;15:1375–83. [57]. van Loon FHJ, Puijin LAPM, Houterman S, Bouwman ARA. Development of the A-DIVA Scale: A Clinical Predictive Scale to Identify Difficult Intravenous Access in Adult Patients Based on Clinical Observations. Medicine Volume 95, Number 16, April 2016 [58]. van Loon FHJ, Hoof LWE, de Boer HD, Koopman SSHA, Buise MP, Korsten HHM et al. The Modified A-DIVA Scale as a Predictive Tool for Prospective Identification of Adult Patients at Risk of a Difficult Intravenous Access: A Multicenter Validation Study. J Clin Med. 2019 Jan 26;8(2):144. [59]. Weisz VR. Risks and benefits of pediatric bone marrow donation: a critical need for research. Behav Sci Law. 1996;14(4):375– 91. https://www.ncbi.nlm.nih.gov/ pubmed/9156419 [60]. Williams S, Green R, Morrison A, Watson D and Buchanan SS. The Psychosocial Aspects of Donating Blood Stem Cells: The Sibling Donor Perspective. Journal of Clinical Apheresis 2003;18:1–9 [61]. Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T et al. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors. Int J Hematol. 2022 Nov 20.